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Rhabdoid tumor is a very aggressive and hardly curable pediatric malignancy. It
commonly starts in the kidneys but also can occur in the brain, liver, and other organs.
The treatment of this tumor usually involves a combination of surgery, radiation, and
chemotherapy. Because this tumor is rare, there is still limited experience with a defined
standard of care. Cytogenetic analysis is an important routine method to monitor
chromosomal aberrations. We have analyzed metaphases of the G-401 rhabdoid tumor
cell line. In these cells we have observed metaphases with derivative chromosome
12 arising from partial trisomy 7p. With increasing passage number the numbers of
metaphases having this derivative chromosome 12 were found to be higher. In passage
number 2 only one metaphase had this pathological chromosome 12. By passage
number 10 and passage number 15 about 25 and 95% of this derivative chromosome
12 were found, respectively. We were able to subclone G-401 cells by limiting dilutions
and successfully separated cells having apparently normal karyotypes from cells having
derivative chromosome 12. Using the cell proliferation assay we showed that clones
possessing the derivative chromosome 12 grew more rapidly than clones with normal
chromosomes. The cell cycle analysis confirmed this observation. Overall, in this study
we describe for the first time a 7p triplication in a rare rhabdoid tumor of kidney. Both
types of clones described in this study could be used as a preclinical model to study the
involvement of partial chromosome 7 alterations in the development of rhabdoid tumors.
Keywords: chromosomal aberration, partial 7p trisomy, pathophysiology, rhabdoid tumor, FISH assay,
proliferation, G-401 cell line
INTRODUCTION
Several types of rare cancers occur predominantly in children and young adults. Rhabdoid
tumors of the kidney are highly malignant neoplasms that most commonly occur within the
first 3 years of childhood. The median age is 11 months and the male:female ratio 1.5:1. Despite
improved knowledge and an increasing number of current methodologies, for many rare cancers
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the identification of causes or development of strategies for
prevention and/or early detection is extremely challenging.
Although rhabdoid tumors of the kidney are generally regarded
as distinct from Wilms tumor, their pathogenesis remains
unclear. The treatment of malignant rhabdoid tumor usually
involves a combination of therapies including surgery, radiation
and chemotherapy. Rhabdoid tumors have been considered
highly malignant with a poor prognosis (1–4).
Within the last 2–3 decades, a significant number of studies
confirmed the relevance of genetic abnormalities for diagnosis,
therapeutic strategies and prognosis of patients.
Chromosomal aberrations have been well-described in many
tumors and tumor cell lines. It is known that chromosomal
heterogeneity can drive critical events such as growth and
survival advantages, progression and karyotype evolution (5–7).
We have analyzed the chromosomes of the G-401 cell line.
This cell line was initially classified as Wilms tumor. However,
many researchers believe that this cell line is of rhabdoid tumor
origin (8). Cytogenetic studies of rhabdoid tumors have revealed
normal karyotypes, a few reports have indicated abnormalities
in chromosome regions 22q, 11p13, and 11p15.5 (9–15). In
particular chromosomal band 11p15.5. was proven to be an
intriguing region of the human genome, since it bears alterations
in a variety of tumors (9). Studies of Wilms tumor and rhabdoid
tumors support the data regarding tumor suppressor properties
of WT2 gene located on 11p15.5 (16–18).
The G-401 cell line was established from a 3-month old
infant (8). In this cell line we have observed some cells
with an aberrant chromosome 12. With increasing passage
numbers more cells with a derivative chromosome 12 have been
observed. The FISH analysis showed that these cells carried an
additional 7p-segment at the end of the one of chromosomes
12q (partial trisomy 7p). In all cells both chromosomes 7 were
structurally normal.
We have subcloned the G-401 by limiting dilutions and
successfully separated cells carrying derivative chromosome
12 from the cells having a normal karyotype. After second
subcloning every third passage has been karyotyped, in total
we have analyzed 33 passages. All clones kept their cytogenetic
features. Using the cell proliferation assay we demonstrated that
clones possessing the derivative chromosome 12 grew more
rapidly than clones with apparently normal chromosomes. The
cell cycle data demonstrated that in cells with the 7p translocation
the G0/G1 phase comprised 75% and G2/M phase comprised 8%,
in contrast in cells which display normal karyotype the G0/G1
and G2/M phase comprised 85 and 6%, respectively.
The DNA profiles of these cells were otherwise identical
to those of normal karyotype and from ATCC, therefore
excluding contamination by other cell cultures. Since the
clones with derivative chromosome 12 have three copies of
the 7p-region we propose that the presence of third gene
alleles of 7p could have provided growth advantage or that
genes located in this locus could regulate the activation of
other genes. We have identified 20 genes which could be
responsible for this faster proliferation of clones having the 7p
translocation and they are a potential target for application of
anti-proliferative drugs.
The clones with normal chromosomes and clones with
derivative chromosome 12 described in this studymight be useful
to further study chromosome 7 alterations and the development
of this pediatric tumor.
MATERIALS AND METHODS
Cells
The rhabdoid tumor cell line G-401 was purchased from
American Type Culture Collection (ATCC number CRL-1442).
Cell line was accompanied by identification test certificate and
was grown in McCoy’s 5a medium according to corresponding
tissue culture collection protocols.
Cell Culture Reagents
Fetal calf serum (FCS) and Dulbecco’s minimal essential medium
(DMEM) were from Bioconcept (Allschwil, Switzerland). All
other cell culture reagents (Trypsin EDTA, Kanamycin, stable
Glutamine) were from BioWest (France). All cell culture
experiments were performed in TPP (Trasalingen, Switzerland)
plastic ware.
Single Cell Cloning by Serial Dilution
G401 cells were cloned by placing 1 cell/well. The cells were
expanded and analyzed by cytogenetic approach. Selected clones
were subcloned second time by placing 0.5 cells/well, expanded
and their karyograms were analyzed as it was previously
described (19). Clones were cultivated until passage 33 and every
third passage was analyzed.
Cytogenetic Studies
Colcemid was from Gibco Life Technologies. Methanol, glacial
acetic acid, Trypan blue solution were from Sigma. Cells were
incubated with colcemid andmetaphases for chromosome spread
were observed under phase contrast microscope as it was
previously described (19). At least 50 metaphases were analyzed.
For image acquisition and analysis of chromosomal bands
(karyotyping) the proprietary software (e.g., Genikon) was used.
Fluorescence in-situ Hybridization (FISH)
FISH probes were from Kreatech/Leica. All chemicals were from
Sigma. Slides were counterstainedwithDAPI and observed under
fluorescence microscope as it was previously described (19).
Proliferation Assay
Ten thousand cells per well of cloned G-401 cells were placed
into 24-well plates in triplicates in 1ml of medium. Cells were
incubated at 37◦C, 5%CO2 and cell count was performed on days
3, 5, 7, and 10 as it was previously described (20).
Cell Cycle Analysis by Flow Cytometry
Cells were stained with propidium iodide (PI) (Thermo Fisher,
USA) and analyzed using a FACSAria SORP cell sorter (Becton
Dickinson, USA) at Ex.561 nm/Em.575–590 nm for cell cycle
distribution as previously described (21). Each measurement was
performed in triplicate.
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Fluorescence Microscopy for Analysis of
Mitotic Cells
Twenty thousand cells were cultivated on 12mm cover glasses
o/n, fixed with Methanol/Acetone (1:1) and stained with DAPI
for 20min at RT as it was described in Tarnowski et al. (22).
Images were collected on Olympus BX-51 microscope with 40X
objective and analyzed using proprietary software. At least 300
nuclei were analyzed and for calculation of the percentage of
mitotic cells the number of mitotic cells was divided to a total
number of investigated nuclei from the same slide× 100%.
Comparative Genome Hybridization (CGH)
-Array
DNA was extracted using DNeasy kit (QIAGEN). CGH-
Array was performed with 4 × 180K array (CGX-HD
from Perkin Elmer) according to manufacturer’s instructions.
After hybridization, the array was scanned in a dual-laser
scanner (Perkin Elmer) and the images were extracted through
CytoGenomics Software (Agilent Technologies) with 37K filter
(Backbone resolution 400 kb (oligos every 100 kb) and resolution
in the targeted regions 40 kb (oligos every 10 kb). All data were
analyzed using Genoglyphix Build Version 3.1-2 (Perkin Elmer).
Identification of Genes
Genes located in the chromosomal regions of interest were
identified and characterized using the Lynx bioinformatics
system (23).
RESULTS
Seventy percent of cancer types diagnosed in children and young
adults under 20 years are rare cancers. We have investigated
rhabdoid tumor cell line G-401. This cell line was established
from a 3-month old infant. In this cell line we have observed
cells with an aberrant chromosome 12 (Figure 1, right side).
With increasing passage numbers more cells with a derivative
chromosome 12 have been observed (Figure 1, left side)
We have subcloned the G-401 using limiting dilutions and
successfully separated cells carrying derivative chromosome 12
from the cells having a normal karyotype. On Figure 2 are shown
the karyogram of the 2E8 clone (46, XY) and the karyogram of the
3D5 clone with a 7p translocation (upper part). The FISH analysis
showed that these cells carried an additional 7p-segment at the
end of the long arm of chromosome 12q (partial trisomy 7p)
(Figure 2, lower part). In all analyzed cells both chromosomes 7
were apparently normal.
After second subcloning every third passage has been
karyotyped, in total 33 passages have been analyzed. All clones
kept their cytogenetic features.
The cell proliferation assay showed that clones possessing the
partial trisomy 7p (derivative chromosome 12) grewmore rapidly
than clones with apparently normal chromosomes (Figure 3A).
On days 3, 7, and 10 there were 1.6 times more cells in clones
with a translocation 7p (1E8 and 3 D5) compared with clones
having normal karyotype and on day 5 there were almost 2 times
more cells in clones with an aberrant chromosome (Figure 3A).
The DNA profiles of these cells were otherwise identical to
those of normal karyotype, therefore excluding contamination by
other cell cultures (data are not shown).
In cell cycle experiments we stained both 2E8 and 3D5 cells
with propidium iodide and analyzed cells on FACSAria. Here
we observed a trend for dividing cell prevalence in 3D5 clone
compared to 2E8 clone (Figure 3B). In 2E8 cells having normal
karyotype the G0/G1, S and G2/M phases comprised 85,33 ±
1,31, 6.6 ± 1,49, and 5.9 ± 0,82%, while in 3D5 cells the G0/G1,
S, and G2/M phases comprised 75,33 ± 4,25, 14,97 ± 0,93, and
8,03± 3,76%, respectively.
We also performed a DAPI staining of 2E8 and 3D5 clones
and counted mitotic cells under fluorescent microscope. In cover
glasses with 2E8 cells we observed approximately 20.35 ± 3.83%
mitotic nuclei and in 3D5 clone 1,7 times more mitotic nuclei
FIGURE 1 | Distribution of normal and pathological metaphases in the G-401 cell line. Metaphases of the G-401 cells. Percentage of normal (46, XY) and pathological
(46,XY,der(12)t(7;12) metaphases in the G-401 cell line is shown in a diagram on a left side. With increasing passage number the numbers of metaphases having this
derivative chromosome 12 (shown on a right side) were higher, n = 50 per passage.
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FIGURE 2 | Karyograms and FISH analysis of 2E8 and 3D5 clones. Karyograms: Chromosomal analysis (karyotyping) of G-401 cell line showed a normal karyotype in
clone 2E8 (46,XY) on left side and a derivative chromosome 12 as sole anomaly in metaphases of clone 3D5 on right side (46,XY,der(12)t(7;12)(p?14;q?24) (upper
part). FISH data: FISH analysis of clones with a normal and aberrant karyotype (2E8 on left side and 3D5 on right side) with commercially available probes WC (Whole
Chromosome) 12 (green) and Sub-Telomere 7p (red) revealed an additional 7p segment at the telomeric site of q-arm of one of chromosome 12 (partial trisomy 7p),
inducated with a white arrow (lower part).
(34,45 ± 2.34%). Figure 3C demonstrates DAPI stained nuclei
in both 2E8 and 3D5 clones. Interestingly, it was not possible to
perform these experiments on synchronized cells: after 30 h of
starvation almost all 2E8 cells died, whereas the clone 3D5 with a
7p translocation continued to do well. For this reason all cell cycle
(n = 3) and DAPI staining experiments (n = 3) were performed
with asynchronized cells.
The CGH-Array was performed to characterizemore precisely
the breakpoint of chromosome rearrangement of derivative
chromosome 12. The results have shown that partial trisomy 7
expanded from the band 7p22.3 until 7p14.3 (Figure 4, upper
part). We have also listed OMIM (Online Mendelian Inheritance
in Man) genes and other genes in this region (Figure 4,
lower part).
Functional characterization of the genes in the
regions of interest using bioinformatics approach
identified a number of genes involved in proliferation
(see Supplementary Table 1).
Since the clones with derivative chromosome 12 have three
copies of the 7p-region we propose that the presence of third gene
alleles of 7p could have provided growth advantage or that genes
located in this locus could regulate the activation of other genes
and promote proliferation. These genes are a potential target for
application of anti-proliferative drugs.
DISCUSSION
Human solid tumor growth and progression is enabled by
the aberrant gene function that positively and negatively
regulates cell proliferation, angiogenesis, migration and invasion.
Chromosomal heterogeneity is observed in many tumor
cell lines. It is understood that chromosomal abnormalities
can confer a selective advantage. It is recommended to
evaluate during extensive cell passaging the karyotypic profile
as a laboratory test control. Currently, microarray based
techniques including comparative genomic hybridization and
single nucleotide polymorphism analysis are widely used to
monitor chromosomal instability. However, classical cytogenetic
analysis is still the gold standard for many routine laboratories.
Here we describe chromosomal aberrations in the G-401 cell
line. In this rhabdoid cell line (formerly classified as Wilms
tumor) we have observed and characterized metaphases with
derivative chromosome 12 arising from partial trisomy 7p. With
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FIGURE 3 | Differences between 2E8 and 3D5 clones in proliferation (A), cell cycle (B), and DAPI staining of the nuclei (C). (A) Proliferation assay: The G-401 cell line
has been cloned by limiting dilutions and the cells with partial trisomy 7p were separated from the cells having a normal karyotype. Two clones with normal
chromosomes and 2 clones with partial trisomy 7p were used in proliferation experiments. Clones with the partial trisomy 7p (1E8 and 3D5) grew more rapidly than the
clones with normal chromosomes (1B11 and 2E8). Cell counts were performed on days 3 (white bars), 5 (light gray bars), 7 (dark gray bars), and day 10 (black bars).
The percentage of dead cells in cultures did not exceed 10%. Values are cell number means ± SEM of three independent sets of experiments with n = 9. (B) Cell
cycle analysis: Asynchronously dividing cells were stained with PI and measured on FACSAria. Linear gates were set on PI fluorescence distribution histogram to mark
G0/G1, S, and G2/M phases of the cell cycle. Cell frequencies in each phase are provided as mean ± SD (n = 3). Representative histograms for 2E8 and 3D5 clones
are shown. In 2E8 clone (left side) the G0/G1 comprised 85.33 ± 1.31%, S comprised 6.6 ± 1.49% and G2/M comprised 5.9 ± 0.82% cells. In 3D5 clone (right side)
G0/G1 phase comprised 75.33 ± 4.25%, S comprised 14.97 ± 0.93%, and G2/M comprised 8.03 ± 3.76%. (C) DAPI staining for identification of mitotic cells:
Asynchronous cultures of 2E8 and 3D5 cells were used for DAPI staining of the nuclei. Mitotic cells are indicated with an arrow. Scale bar 50µM. 2E8 cells (46, XY)
(on left side) and 3D5 cells (46,XY,der(12)t(7;12) (on right side) were digitally imaged on an Olympus microscope. Mitotic cells are recognized by the bright DAPI
staining of their condensed chromatin.
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FIGURE 4 | Results of Comparative Genom Hybridization (CGH) array. Full genome profile from Genoglyphix is shown. Terminal gain of chromosome 7p22.3p14.3
Array Result: arr[GRCh37/hg19] 7p22.3p14.3(187243_31346787)x3 (upper part). Genes located in the region of interest are listed: 146 Online Mendelian Inheritance
in Man (OMIM) genes and 121 other genes (lower part).
increasing passage number the numbers of metaphases having
this derivative chromosome 12 were found to be higher. We
were able to subclone G-401 cells by limiting dilutions at passage
12 and successfully separated cells having normal karyotypes
from cells having partial trisomy 7p (derivative chromosome
12). Notably cells possessing partial trisomy 7p grew more
rapidly compared to the normal karyotype. These findings were
demonstrated using proliferation assay, cell cycle experiments
and with DAPI staining.
Standard chromosomal investigations alone or combined with
other techniques such as fluorescent in-situ hybridization (FISH)
can be used to confirm observational chromosomal aberrations
and can be applied to investigate any tumor cell line particularly
applicable for possibly heterogeneous primary cell populations.
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Chromosomal aberrations in chromosome 7 are often
observed in brain, blood and many other tumors (24–26).
An unbalanced der(12)t(7;12) translocation was described in
a patient with childhood T-cell acute lymphoblastic leukemia
(27). It was speculated that this translocation may be involved
in leukemogenesis, but further investigations were not possible
because this patient died with the second relapse.
In present study we describe for the first time a 7p
triplication in a rare rhabdoid tumor of kidney. It was a sole
anomaly in metaphases of the G-401 cell line. Interestingly, both
chromosomes 7 are structurally normal. It is unclear when and
how this translocation appeared on one of the chromosomes
12 in this cell line. This (der12)t(7;12) translocation is stable,
we passaged the clones for a long time (over 33 passages) and
all investigated clones kept this 7p translocation. Both clones
with a normal karyotype (1B11 and 2E8) did not show any
chromosomal abnormalities over 33 passages and had a normal
46, XY karyotype.
Since the clones with partial trisomy 7p have three copies of
the 7p-region we propose that the presence of third gene alleles
of 7p could have provided the growth advantage or that the genes
located in this locus could regulate the activation of other genes
and promote the proliferation. In Supplementary Table 1 (which
contains information about Gene symbol, Gene description,
Refseq summary and Cancer gene index) are listed the genes
which may contribute to a faster proliferation of clones with
7p triplication. Among these genes are Il-6, PDGFA, ETV-1,
and RAC-1.
Il-6 is a pleiotropic cytokine that plays an important role
in inflammation and the maturation of B-cells. It induces
proliferation, differentiation and dedifferentiation and acts on
many cells (28, 29).
PDGFA protein is involved in a number of biological
processes, including hyperplasia, embryonic neuron
development. It is a strong mitogen for a variety of cell
types, e.g., connective tissue, smooth muscle cells, and bone
cells (30–32).
ETV1 protein encoded by ETV gene is a member of the
ETS (E twenty-six) family of transcription factors. The ETS
proteins regulate many target genes that modulate biological
processes like cell growth, angiogenesis, migration, proliferation
and differentiation (33, 34).
RAC1 protein encoded by RAC1 gene regulates many
cellular events including the control of cell growth, cytoskeletal
reorganization, and the activation of protein kinases (35, 36).
The clones with normal chromosomes and clones with partial
trisomy 7p described in this study could be used as a preclinical
model to study the involvement of partial chromosome 7
alterations in the development of rhabdoid tumors. These models
might be also used for evaluating of anti-cancer drugs in
preclinical studies.
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